SummaryPatients with coronary artery disease presenting for major noncardiac surgery may have indications for both peri-operative b-blockade and haemodynamic optimisation. The combination of peri-operative cardiorespiratory failure and myocardial ischaemia has a grave prognosis. Recent investigations have shown that in patients with coronary artery disease, b-blockade does not depress cardiac output as much as originally thought. There may, therefore, be a place for both peri-operative b-blockade and haemodynamic optimisation. The indications for peri-operative b-blockade and haemodynamic optimisation, the effect of acute b-blockade on cardiac output in patients with coronary artery disease, and the interaction of peri-operative b-blockade and haemodynamic optimisation are discussed.Keywords Sympathetic nervous system; beta-adrenergic blockade. anaesthesia. myocardial ischaemia. Since the article by Juste et al. in 1996 [1], a number of studies have added to our understanding of peri-operative b-blockade and haemodynamic optimisation. These include the indications for peri-operative b-blockade and haemodynamic optimisation, the tolerance of acute b-blockade in patients with both coronary artery disease (CAD) and poor exercise capacity, and issues regarding both acute and chronic b-blockade during haemodynamic optimisation.Indications for peri-operative b-blockade